These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24729078)

  • 1. Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
    McDonald EM; Ram FS; Patel DV; McGhee CN
    Br J Ophthalmol; 2014 Nov; 98(11):1470-7. PubMed ID: 24729078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies.
    Hanet MS; Jamart J; Chaves AP
    Can J Ophthalmol; 2012 Dec; 47(6):493-9. PubMed ID: 23217502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.
    Durrani AF; Atta S; Bhat AK; Mammen A; Dhaliwal D; Kowalski RP; Jhanji V
    Am J Ophthalmol; 2020 Jun; 214():119-126. PubMed ID: 32209347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones in the treatment of bacterial keratitis.
    Bower KS; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of fortified antibiotics and fluoroquinolones for the treatment of bacterial keratitis: A meta-analysis.
    Zhou R; Wang Q; Yuan L; Zhou H; Xue J
    J Fr Ophtalmol; 2024 May; 47(5):103940. PubMed ID: 37741755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy versus fortified antibiotics for bacterial keratitis.
    Rosenberg JB; Gritz DC
    Cornea; 2011 Sep; 30(9):1066; author reply 1066-7. PubMed ID: 21775886
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxifloxacin for bacterial keratitis.
    Rosenberg J; Eisen L; Kim J
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
    Palioura S; Gibbons A; Miller D; OʼBrien TP; Alfonso EC; Spierer O
    Cornea; 2018 Mar; 37(3):326-330. PubMed ID: 29408828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
    Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
    Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection.
    Vyas U; Desai T; Shah C
    J Indian Med Assoc; 2002 Jun; 100(6):398-9. PubMed ID: 12416674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.
    Gangopadhyay N; Daniell M; Weih L; Taylor HR
    Br J Ophthalmol; 2000 Apr; 84(4):378-84. PubMed ID: 10729294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Besifloxacin in the management of bacterial infections of the ocular surface.
    Deschênes J; Blondeau J
    Can J Ophthalmol; 2015 Jun; 50(3):184-91. PubMed ID: 26040217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.